Bayer HealthCare is among the world’s foremost innovators of pharmaceutical and medical products. Our mission is to research, develop, manufacture and market innovative therapies that improve the lives of humans and animals throughout the world. Bayer HealthCare researches and develops prescription medicines in areas of medical need, such as cancer therapy and cardiovascular disease.
In 2010, Bayer invested a total of EUR 3.1 billion in research and development of which EUR 2 billion went directly into healthcare research. With this investment, the company is laying the foundation for introducing further innovative products to improve health and quality of life.
The global Health Care subgroup is divided into four operating divisions: The goals of Animal Health are to maintain the health of animals and cure veterinary diseases, focusing primarily on treating infectious diseases and repelling parasites. The main focus of Consumer Care is on non-prescription medicines and dietary supplements. One example is Aspirin, a more than 110-year-old brand that is recognised globally. Medical Care includes Diabetes Care, providing blood glucose monitoring technology and Radiology and Interventional with equipment for diagnosis and treatment.
The Pharmaceuticals division is a worldwide leader in its main therapeutic areas focussing on prescription medicines. The division combines its strengths in two areas: General Medicine and Specialty Medicine.